# Borgeson John A.: insider transactions

SEC CIK 1754045. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-23.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Kodiak Sciences Inc.](/companies/kod.md) | Chief Financial Officer, Officer | 10 | 2026-10-21 | 2026-10-21 |

## Transactions: 10

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Option exercise (M), derivative | 30,000 | $0.00 | $0 | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 100 | $94.91 | $9.5k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 2,000 | $93.71 | $187.4k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 2,000 | $92.66 | $185.3k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 2,985 | $91.76 | $273.9k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 5,101 | $90.98 | $464.1k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 7,623 | $89.74 | $684.1k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 1,677 | $89.20 | $149.6k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Sale (S) | 8,514 | $87.67 | $746.4k | [Form 4](/filings/0001754045-26-000010.md) |
| 2026-10-21 | [Kodiak Sciences Inc.](/companies/kod.md) | Option exercise (M) | 30,000 | $2.49 | $74.7k | [Form 4](/filings/0001754045-26-000010.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 03:51 ET. No prices; not investment advice.